Additionally, FBXL5 binds to RhoGDP dissociation inhibitor beta (RhoGDI2), reducing RhoGDI2-mediated cisplatin resistance in gastric cancer cells (111). The gene discussed is ARHGDIB; the disease is gastric cancer.